Bruker Corporation
Bruker Corporation (BRKR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BRKR · as of Jun 8, 2026
Key Statistics
Explore Bruker Corporation Data
brkr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 32 · Buy rate: 50.0%
The BRKR analyst consensus is Buy, based on ratings from 32 Wall Street analysts over the past 3 months. The average 12-month price target is $50.13, representing -11.10% downside from the current price of $56.39.
Competitors & Peers
brkr competitorsBRKR
BTSG
CHE
CRSP
GKOS
IRTCStock Performance
Full HistoryAbout Bruker Corporation
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three …
what is bruker corporation · brkr stock overview · bruker corporation company profile · who is bruker corporation ceo · brkr NASDAQ · bruker corporation headquarters · bruker corporation business segments
About Stock Overview & Key Data
Bruker Corporation (BRKR) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Aug 4, 2000. As of the latest trading session, BRKR stock price is $56.39, with a market capitalization of $8.6B. The stock has returned +43.82% over the past 12 months and +19.70% year-to-date.
According to 32 Wall Street analysts, the consensus rating for Bruker Corporation stock is Buy, with an average 12-month price target of $50.13. In fiscal year 2025, Bruker Corporation reported revenue of $3.4B and net income of -$8.6M. For detailed data — including Bruker Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bruker Corporation (BRKR) stock price is $56.39. The stock is traded on NASDAQ under the ticker symbol BRKR. The 52-week range is $28.53 – $63.02.